Search Within

Aseem Anand

Formats
  1. Meeting Abstract (42)
  2. Journal Article (19)
Groups
  1. Department of Medicine (52)
  2. Genitourinary Oncology Service (52)
  3. Solid Tumor Oncology Division (52)
  4. Epidemiology and Biostatistics (21)
  5. GSK Faculty (21)
  6. Biostatistics Service (20)

More Groups

People
  1. Howard Scher (46)
  2. Martin Fleisher (34)
  3. Daniel Danila (33)
  4. Glenn Heller (19)
  5. Michael Morris (15)
  6. Hans Lilja (10)

More People

Years
  1. 2025 (1)
  2. 2022 (3)
  3. 2020 (1)
  4. 2019 (2)
  5. 2018 (2)
  6. 2017 (2)

More Years

Publications
  1. Journal of Clinical Oncology (35)
  2. Clinical Cancer Research (3)
  3. Journal of Nuclear Medicine (3)
  4. Clinical Chemistry (2)
  5. European Urology (2)
  6. Journal of Molecular Diagnostics (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (35)
  2. Elsevier Science, Inc. (6)
  3. American Association for Cancer Research (5)
  4. Society of Nuclear Medicine (3)
  5. Springer (3)
  6. American Association for Clinical Chemistry (2)

More Publishers

Results (61)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genomic analysis of circulating tumor cells to evaluate predictive biomarkers
    Meeting Abstract

    Danila, D. C.; Anand, A.; Yao, J.; Gierszewska, M.; Kramer, M.; Fleisher, M.; Sawyers, C. L.; McCombie, W. R.; Scher, H. I.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Molecular profiling of circulating tumor cells (CTC) in patients with castrate resistant prostate cancer (CRPC) receiving abiraterone acetate (AA) after failure of docetaxel-based chemotherapy
    Meeting Abstract

    Danila, D. C.; Anand, A.; Sung, C. C.; Leversha, M.; Cao, L.; Fleisher, M.; Scher, H. I.
    Cancer Research (2011)

    Fulltext@MSK | Save
  • TMPRSS2-ERG Status in circulating tumor cells as a predictive biomarker of sensitivity in castration-resistant prostate cancer patients treated with abiraterone acetate
    Journal Article

    Danila, D. C.; Anand, A.; Sung, C. C.; Heller, G.; Leversha, M. A.; Cao, L.; Lilja, H.; Molina, A.; Sawyers, C. L.; Fleisher, M.; more...
    European Urology (2011)

    Fulltext@MSK | Save
  • Long-term efficacy results from the phase 1-2 study of MDV3100 in pre-and post-docetaxel advanced prostate cancer
    Meeting Abstract

    Higano, C.; Beer, T.; Yu, E.; Taplin, M. E.; Efstathiou, E.; Anand, A.; Hirmand, M.; Fleisher, M.; Scher, H.
    European Urology, Supplements (2011)

    Fulltext@MSK | Save
  • Phase I dose-escalation study of the novel antiandrogen BMS-641988 in patients with castration-resistant prostate cancer
    Journal Article

    Rathkopf, D.; Liu, G.; Carducci, M. A.; Eisenberger, M. A.; Anand, A.; Morris, M. J.; Slovin, S. F.; Sasaki, Y.; Takahashi, S.; Ozono, S.; more...
    Clinical Cancer Research (2011)

    Fulltext@MSK | Save
  • A gene expression signature associated with sensitivity to the multikinase inhibitor dasatinib: Implications for development of a noninvasive biomarker for personalized therapy based on circulating tumor cell analysis
    Meeting Abstract

    Mitsiades, N.; Antipin, Y.; Reva, B.; Schultz, N.; Danila, D. C.; Sung, C. C.; Anand, A.; Sander, C.; Scher, H. I.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Molecular profiling of circulating tumor cells (CTC) in patients with castrate metastatic prostate cancer (CMPC) receiving abiraterone acetate (AA) after failure of docetaxel-based chemotherapy
    Meeting Abstract

    Danila, D. C.; Anand, A.; Sung, C. C.; Leversha, M.; Rathkopf, D. E.; Morris, M. J.; Slovin, S. F.; Molina, A.; Fleisher, M.; Scher, H. I.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Circulating tumor cells (CTC) and prostate specific antigen (PSA) as response indicator biomarkers in chemotherapy-naive patients with progressive castration-resistant prostate cancer (CRPC) treated with MDV3100
    Meeting Abstract

    Anand, A.; Scher, H. I.; Beer, T. M.; Higano, C. E.; Danila, D. C.; Taplin, M.; Efstathiou, E.; Hirmand, M.; Sawyers, C. L.; Heller, G.; more...
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • A phase I study of oral panobinostat alone and in combination with docetaxel in patients with castration-resistant prostate cancer
    Journal Article

    Rathkopf, D.; Wong, B. Y.; Ross, R. W.; Anand, A.; Tanaka, E.; Woo, M. M.; Hu, J.; Dzik-Jurasz, A.; Yang, W.; Scher, H. I.
    Cancer Chemotherapy and Pharmacology (2010)

    Fulltext@MSK | Save
  • Phase II multicenter study of abiraterone acetate plus prednisone therapy in patients with docetaxel-treated castration-resistant prostate cancer
    Journal Article

    Danila, D. C.; Morris, M. J.; de Bono, J. S.; Ryan, C. J.; Denmeade, S. R.; Smith, M. R.; Taplin, M. E.; Bubley, G. J.; Kheoh, T.; Haqq, C.; more...
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save